{"canonical":"https://abierto.us/vendors/universitat-st-gallen-llk6d5m1uaf1","key":"LLK6D5M1UAF1","name":"UNIVERSITAT ST. GALLEN","uei":"LLK6D5M1UAF1","city":"ST. GALLEN","state":null,"awards":2,"obligated":"515769.84","notices_won":9,"top_agency_name":"Food and Drug Administration","top_naics":"541714","cage":"SZA17","parent_name":"UNIVERSITAT ST. GALLEN","also_known_as":[],"country":"CHE","actions":2,"first_action":"2024-04-10","last_action":"2025-09-08","breakdowns":{"naics":[{"key":"541714","name":null,"awards":2,"obligated":"515769.84"}],"places":[{"key":"MD","name":null,"awards":2,"obligated":"515769.84"}],"agencies":[{"key":"7524","name":"Food and Drug Administration","awards":2,"obligated":"515769.84"}],"award_types":[{"key":"DEFINITIVE CONTRACT","name":null,"awards":2,"obligated":"515769.84"}],"competition":[{"key":"FULL AND OPEN COMPETITION","name":null,"awards":2,"obligated":"515769.84"}],"product_service_codes":[{"key":"AJ11","name":null,"awards":1,"obligated":"515769.89"},{"key":"AN11","name":null,"awards":1,"obligated":"-0.05"}]},"awards_list":[{"award_key":"CONT_AWD_75F40125C00063_7524_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_75F40125C00063_7524_-NONE-_-NONE-/","piid":"75F40125C00063","parent_piid":null,"award_type":"DEFINITIVE CONTRACT","vendor_key":"LLK6D5M1UAF1","recipient_name":"UNIVERSITAT ST. GALLEN","recipient_uei":"LLK6D5M1UAF1","recipient_cage":"SZA17","recipient_city":"ST. GALLEN","recipient_state":null,"sub_name":"Food and Drug Administration","office_name":"FDA OFFICE OF ACQ GRANT SVCS","office_key":"o-75F401","first_action_date":"2025-09-08","last_action_date":"2025-09-08","actions":1,"obligated":"515769.89","current_total_value":"515769.89","potential_total_value":"515769.89","naics":"541714","psc":"AJ11","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":1,"description":"THE PURPOSE OF THIS CONTRACT IS TO CONDUCT RESEARCH AND DEVELOP TOOLS TO STRENGTHEN POST-MARKET SURVEILLANCE OF FDA-REGULATED PRODUCTS. THE OBJECTIVE IS TO APPLY ADVANCED ANALYTICS AND HYBRID ARTIFICIAL INTELLIGENCE TO IMPROVE RISK IDENTIFICATION USI","method":null,"confidence":null,"evidence":null,"opportunity_key":"FDABAA2500123","opportunity_title":"FY25 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science"},{"award_key":"CONT_AWD_75F40121C00161_7524_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_75F40121C00161_7524_-NONE-_-NONE-/","piid":"75F40121C00161","parent_piid":null,"award_type":"DEFINITIVE CONTRACT","vendor_key":"LLK6D5M1UAF1","recipient_name":"UNIVERSITAT ST. GALLEN","recipient_uei":"LLK6D5M1UAF1","recipient_cage":"SZA17","recipient_city":"ST. GALLEN","recipient_state":null,"sub_name":"Food and Drug Administration","office_name":"FDA OFFICE OF ACQ GRANT SVCS","office_key":"o-75F401","first_action_date":"2024-04-10","last_action_date":"2024-04-10","actions":1,"obligated":"-0.05","current_total_value":"764418.19","potential_total_value":"764418.19","naics":"541714","psc":"AN11","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":1,"description":"FOLLOWING THE PUBLICATION OF THE US FOOD AND DRUG ADMINISTRATION SAFETY AND INNOVATION ACT (FDASIA) IN 2012, AND THE SUBSEQUENT ESTABLISHMENT OF A PUBLIC DOCKET IN JULY 2013, THE FDA ANNOUNCED ITS INTENTION TO EXAMINE THE USE OF SELECTED QUALITY METR","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null}],"awards_total":2,"awards_page":1,"won":[],"won_total":0,"solicitations_won":[]}